BIIB EBITDA Growth
Biogen · EBITDA Growth
BIIB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-42.15%period ending
BIIB TTM EBITDA YoY % (19.83% → -42.15%)
Year-over-year change
High-resolution chart · PNG
BIIB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -42.152% | |
| -19.2802% | |
| -9.3774% | |
| 14.0246% | |
| 23.173% | |
| 28.1842% | |
| 32.7051% | |
| 20.5928% | |
| -11.1823% | |
| -25.2654% | |
| -32.7943% | |
| -27.0982% | |
| -11.5632% | |
| 10.0062% | |
| 4.7567% | |
| 40.7268% | |
| 29.7409% | |
| -26.277% | |
| -33.707% | |
| -65.2864% | |
| -66.4244% | |
| -47.8951% | |
| -34.2304% | |
| -7.846% | |
| 4.5863% | |
| 13.4121% | |
| 10.3925% | |
| 12.8943% | |
| 14.0031% | |
| 3.9204% | |
| 5.8471% | |
| 5.1217% | |
| 7.0514% | |
| 5.9794% | |
| 3.5435% | |
| 4.3361% | |
| 2.1535% | |
| 8.9292% | |
| 13.9814% | |
| 13.8206% | |
| 16.982% | |
| 16.7696% | |
| 20.6074% | |
| 31.5967% | |
| 41.8196% | |
| 50.9852% | |
| 52.7007% | |
| 52.2508% | |
| 46.9006% | |
| 41.9378% | |
| 37.2752% | |
| 25.1007% | |
| 16.9051% | |
| 14.598% | |
| 1.6077% | |
| 2.472% | |
| 16.7784% | |
| 11.1776% | |
| 34.9222% | |
| 29.0459% | |
| -0.4984% | |
| 6.0969% | |
| -9.8183% | |
| -6.3421% | |
| 6.8501% | |
| -2.2026% | |
| 5.3176% | |
| 6.7457% | |
| 18.2646% | |
| 27.8271% | |
| 30.0367% | |
| 42.3513% | |
| 22.2485% | |
| 64.2275% | |
| 50.8671% | |
| 45.0387% | |
| 89.1387% | |
| 4.0657% | |
| 30.1571% | |
| 24.824% | |
| -9.4428% | |
| 23.6227% | |
| 27.8747% | |
| 186.5552% | |
| 181.3817% | |
| 171.6521% | |
| 159.5169% | |
| -356.135% | |
| -399.5409% | |
| -389.8426% | |
| -353.5944% | |
| -21.2464% | |
| -32.0839% | |
| -28.2023% | |
| -20.108% | |
| -16.4938% | |
| 13.0033% | |
| 19.2454% | |
| 17.9942% | |
| 8.4343% |